
Tetrahedron p. 11619 - 11639 (1999)
Update date:2022-08-04
Topics:
Siegel, Miles G.
Chaney, Michael O.
Bruns, Robert F.
Clay, Michael P.
Schober, Douglas A.
Van Abbema, Anne M.
Johnson, Douglas W.
Cantrell, Buddy E.
Hahn, Patric J.
Hunden, David C.
Gehlert, Donald R.
Zarrinmayeh, Hamideh
Ornstein, Paul L.
Zimmerman, Dennis M.
Koppel, Gary A.
This study describes the integrated application of parallel synthesis and computational chemistry to the design of potent nonpeptide antagonists for the neuropeptide Y-1 (NPY1) receptor. A lead molecule was modeled in the active site of the NPY1 receptor, and a potentially fruitful region for analog construction was identified. Synthesis of suitable scaffolds followed by solution phase generation of a small library of analogs produced a compound with 5-fold improvement in binding over the already potent lead. This new compound was shown to be an unanticipated side product of the parallel synthesis reaction.
View MoreContact:+86-518-81061113
Address:No. 8 Lingzhou Road, Lianyungang, Jiangsu, China
Hangzhou Share Chemical Co., Ltd(expird)
Contact:+86-57187093700
Address:Hang Xing Road
Binzhou Holly Pharmaceutical Co.,Ltd.
Contact:74517
Address:No.15 Dapu Road,Huangpu District Shanghai,P.R.China
Nanjing Zelang Medical Technology Co. Ltd
Contact:86-25-83063290/13770714480
Address:Ganjiabian 108# 01 Unit,701-702 room,Yao Hua Street,Qixia District,Nanjing,Jiangsu,China
Hubei Xiangxi Chemical Industry Co.,Ltd
Contact:+86-710-3454830
Address:No.7, Daqing East Road, Xiangfan City, Hubei Province, China
Doi:10.1021/jo01258a002
(1969)Doi:10.1021/jo981950u
(1999)Doi:10.1021/jo050680u
(2005)Doi:10.1021/jm100459k
(2010)Doi:10.1016/S0040-4039(97)01428-7
(1997)Doi:10.1021/om970378e
(1997)